FDx Advisors’s Charles River Laboratories CRL Stock Holding History

FDx Advisors’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,621	Closed	-$710K	–	231
2024 Q1	$710K	Sell	2,621 -1,018	-28%	-$276K	0.11%	165
2023 Q4	$860K	Sell	3,639 -452	-11%	-$107K	0.07%	290
2023 Q3	$802K	Sell	4,091 -4,829	-54%	-$947K	0.07%	260
2023 Q2	$1.88M	Sell	8,920 -611	-6%	-$129K	0.1%	199
2023 Q1	$2.08M	Hold	9,531	–	–	0.09%	190
2022 Q4	$2.08M	Sell	9,531 -1,934	-17%	-$421K	0.09%	190
2022 Q3	$2.26M	Sell	11,465 -1,793	-14%	-$353K	0.1%	172
2022 Q2	$2.84M	Buy	13,258 +252	+2%	+$53.9K	0.11%	171
2022 Q1	$3.69M	Buy	13,006 +355	+3%	+$101K	0.13%	137
2021 Q4	$4.77M	Buy	12,651 +892	+8%	+$336K	0.13%	131
2021 Q3	$4.85M	Buy	11,759 +950	+9%	+$392K	0.15%	115
2021 Q2	$4M	Buy	10,809 +1,107	+11%	+$409K	0.13%	132
2021 Q1	$2.81M	Buy	9,702 +4,722	+95%	+$1.37M	0.11%	147
2020 Q4	$1.24M	Buy	4,980 +1,034	+26%	+$258K	0.05%	229
2020 Q3	$894K	Sell	3,946 -1,637	-29%	-$371K	0.04%	254
2020 Q2	$973K	Buy	5,583 +2,580	+86%	+$450K	0.05%	233
2020 Q1	$379K	Sell	3,003 -763	-20%	-$96.3K	0.02%	344
2019 Q4	$575K	Sell	3,766 -20	-0.5%	-$3.05K	0.03%	322
2019 Q3	$501K	Buy	3,786 +334	+10%	+$44.2K	0.03%	341
2019 Q2	$490K	Sell	3,452 -28	-0.8%	-$3.98K	0.02%	493
2019 Q1	$505K	Sell	3,480 -587	-14%	-$85.2K	0.02%	463
2018 Q4	$460K	Sell	4,067 -1,130	-22%	-$128K	0.04%	320
2018 Q3	$699K	Buy	5,197 +756	+17%	+$102K	0.03%	423
2018 Q2	$499K	Sell	4,441 -62	-1%	-$6.97K	0.02%	547
2018 Q1	$481K	Sell	4,503 -1,055	-19%	-$113K	0.01%	784
2017 Q4	$608K	Buy	5,558 +485	+10%	+$53.1K	0.02%	718
2017 Q3	$548K	Buy	+5,073	New	+$548K	0.02%	763
2015 Q1	–	Sell	-4,326	Closed	-$275K	–	1879
2014 Q4	$275K	Buy	4,326 +92	+2%	+$5.85K	0.02%	751
2014 Q3	$253K	Buy	4,234 +79	+2%	+$4.72K	0.02%	843
2014 Q2	$222K	Buy	+4,155	New	+$222K	0.01%	906